SCHEMBL1897993

SCHEMBL1897993

CC(C)C[C@H](N)C(=O)Oc1cccs1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 1/20 0.41
MMP2 P08253 1/20 0.41
MMP9 P14780 1/20 0.41
MMP12 P39900 1/20 0.41
SLC1A3 P43003 1/20 0.38
SLC1A2 P43004 1/20 0.38
SLC1A1 P43005 1/20 0.38
SLC7A5 Q01650 1/20 0.38
ALOX5 P09917 1/20 0.38
LARS1 Q9P2J5 1/20 0.38
RAB9A P51151 2/20 0.37
NPC1 O15118 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
ANPEP P15144 1/20 0.37
RNPEP Q9H4A4 1/20 0.37
DNPEP Q9ULA0 1/20 0.37
ELANE P08246 1/20 0.37
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29159324 0.98 MMP1 (0.40) MMP1MMP2MMP9MMP12SLC1A3
SCHEMBL2009145 0.83 MMP1 (0.41) MMP1MMP2MMP9MMP12SLC1A3
SCHEMBL3399442 0.82 MMP1 (0.43) MMP1MMP2MMP9MMP12SLC1A3
SCHEMBL41616 0.82 MMP1 (0.43) MMP1MMP2MMP9MMP12SLC1A3
SCHEMBL9878919 0.82 KIF11 (0.40) MMP1MMP2MMP9MMP12SLC1A3
SCHEMBL58410 0.81 MMP2 (0.40) MMP1MMP2MMP9MMP12SLC1A3
SCHEMBL4350616 0.80 KIF11 (0.41) MMP1MMP2MMP9MMP12SLC1A3
SCHEMBL8430877 0.79 MMP1 (0.38) MMP1MMP2MMP9MMP12SLC1A3
SCHEMBL28244620 0.79 MMP1 (0.38) MMP1MMP2MMP9MMP12SLC1A3
SCHEMBL8228297 0.79 MMP1 (0.45) MMP1MMP2MMP9MMP12ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0765117-B1 BIOLOGICAL CONTROL OF INSECTS UNIV TROBE (AU) 2004-02-18 EP claimed
US-20030228314-A1 ERAAP modulators regulate immune responses THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2003-12-11 US claimed
WO-2003099852-A2 PEPTIDE DERIVATIZATION PROCESS RESTORAGEN INC. (US) 2003-12-04 WO claimed
CN-114929217-A Pharmaceutical composition for treating multiple sclerosis based on AMPK inhibitory function and zinc homeostasis control function 锌医疗公司 2022-08-19 CN disclosed
US-20110105959-A1 Novel Methods for Bone Treatment by Modulating an Arachidonic Acid Metabolic or Signaling Pathway ACCELALOX, INC. (US) 2011-05-05 US disclosed
WO-2009105723-A2 NOVEL METHODS FOR BONE TREATMENT BY MODULATING AN ARACHIDONIC ACID METABOLIC OR SIGNALING PATHWAY ACCELALOX, INC. (US) 2009-08-27 WO disclosed
US-7232570-B2 ERAAP modulators regulate immune responses REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2007-06-19 US disclosed
US-7232570-B2 ERAAP modulators regulate immune responses REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2007-06-19 US disclosed
US-20060099217-A1 ERAAP modulators regulate immune responses THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2006-05-11 US disclosed
US-20060099217-A1 ERAAP modulators regulate immune responses THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2006-05-11 US disclosed
US-7005269-B2 ERAAP modulators regulate immune responses THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2006-02-28 US disclosed
US-7005269-B2 ERAAP modulators regulate immune responses THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2006-02-28 US disclosed
US-20030228314-A1 ERAAP modulators regulate immune responses THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2003-12-11 US disclosed
US-20030228314-A1 ERAAP modulators regulate immune responses THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2003-12-11 US disclosed
WO-2003099852-A2 PEPTIDE DERIVATIZATION PROCESS RESTORAGEN INC. (US) 2003-12-04 WO disclosed